BEAM
Beam Therapeutics Inc
NASDAQ: BEAM · HEALTHCARE · BIOTECHNOLOGY
$29.38
-3.86% today
Updated 2026-04-29
Market cap
$3.02B
P/E ratio
—
P/S ratio
21.60x
EPS (TTM)
$-0.81
Dividend yield
—
52W range
$15 – $36
Volume
2.1M
Beam Therapeutics Inc (BEAM) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |